Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mizuho Nonaka"'
Autor:
Kumiko Ogawa, Kouhei Amakasu, Takuya Nishimura, Yukie Saegusa, Misaki Naota, Akiyoshi Nishikawa, Mizuho Nonaka
Publikováno v:
Regulatory toxicology and pharmacology : RTP. 86
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) has been conducting a prospective evaluation period to validate the criteria for waiving some carcinogenicity studies in rats.
Aberrant NF-κB2/p52 expression in Hodgkin/Reed–Sternberg cells and CD30-transformed rat fibroblasts.
Autor:
Mizuho Nonaka1, Ryouichi Horie2, Kinji Itoh3, Toshiki Watanabe4, Naoki Yamamoto1 shojmmb@tmd.ac.jp, Shoji Yamaoka1
Publikováno v:
Oncogene. 6/2/2005, Vol. 24 Issue 24, p3976-3986. 11p.
Autor:
Mizuho Nonaka, Yasunori Saitoh, Shizuko Ichinose, Naoki Yamamoto, Tohti Amet, Xiaohua Qi, Md. Zahidunnabi Dewan, Shoji Yamaoka
Publikováno v:
Microbes and Infection. 10:471-480
Latent infection of human immunodeficiency virus type 1 (HIV-1) represents a major hurdle in the treatment of acquired immunodeficiency syndrome (AIDS) patients. Statins were recently reported to suppress acute HIV-1 infection and reduce infectious v
Publikováno v:
Oncogene. 24:3976-3986
Overexpression of CD30 and constitutive nuclear factor-kappaB (NF-kappaB) activation are hallmarks of the malignant Hodgkin Reed-Sternberg (H-RS) cells. Previous investigations have demonstrated that both proliferation and survival of H-RS cells requ
Publikováno v:
Cancer Cell International
Cancer Cell International, Vol 9, Iss 1, p 20 (2009)
Cancer Cell International, Vol 9, Iss 1, p 20 (2009)
The human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces apoptosis after cell cycle arrest at the G2 phase in primate cells. We have reported previously that C81, a carboxy-terminally truncated form of Vpr, interferes with cell p
Autor:
Mizuho Nonaka, Go Matsuda, Megumi Matsuyama, Yoshie Hashimoto, Shin-nosuke Takeshima, Yoko Aida, Suzuki Tatsunori, Rie Tanaka, Tomoyuki Miura, Norio Yamamoto, Shingo Kato, Tatsuhiko Igarashi
Publikováno v:
Biochemical and biophysical research communications. 380(4)
The development of multidrug-resistant viruses compromises the efficacy of anti-human immunodeficiency virus (HIV) therapy and limits treatment options. Therefore, new targets that can be used to develop novel antiviral agents need to be identified.
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 65
Publikováno v:
The Kurume Medical Journal. 17:49-53